Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendtsen, Lars, Sacco, Simona, Ashina, Messoud, Mitsikostas, Dimos, Ahmed, Fayyaz, Pozo-Rosich, Patricia, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Consensus Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755553/
https://www.ncbi.nlm.nih.gov/pubmed/30259200
http://dx.doi.org/10.1186/s10194-018-0921-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755553/
https://www.ncbi.nlm.nih.gov/pubmed/30259200
http://dx.doi.org/10.1186/s10194-018-0921-8

Ejemplares similares